Interestingly, a recent study of copy number alterations in 125 localized prostate tumors identified a recurrent amplification of region of chromosome 1q22.3, spanning the ADAR gene, that was significantly associated with early prostate cancer specific mortality [49]. This evidence concerns the gene ADAR and prostate carcinoma.